These PKC activators elicit a variety of responses characteristic of tumor cells, including stimulation of cell proliferation, decreased sensitivity to apoptosis, increased cell-matrix adhesion and cell migration/invasion [17,18]. This evidence concerns the gene PRRT2 and neoplasm.